NCT00152269View on ClinicalTrials.gov

Treatment of Uterine Fibroids With Asoprisnil(J867)

PHASE3CompletedINTERVENTIONAL

Enrollment

475

Participants

Timeline

Start Date

July 31, 2002

Primary Completion Date

January 31, 2005

Study Completion Date

January 31, 2005

Conditions

LeiomyomaMenorrhagiaMetrorrhagia

Interventions

DRUG

Asoprisnil

10mg Tablet, oral Daily for 12 months

DRUG

Asoprisnil

25mg Tablet, oral Daily for 12 months

DRUG

Placebo

Placebo, Tablet, oral Daily for 12 months

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Abbott

INDUSTRY

NCT00152269 - Treatment of Uterine Fibroids With Asoprisnil(J867) | Biotech Hunter | Biotech Hunter